Group 1 - Fintech company Findi is facing legal issues after a user claimed misconduct on forums, prompting the company's legal team to get involved [2] - PainChek's app for aged care homes received FDA approval, leading to increased attention as the company now focuses on sales [3] - Mesoblast's stock is gaining traction again as its stem cell drug Ryoncil shows sales momentum in the USA [4] Group 2 - Race Oncology's stock reached an all-time high after revealing the mechanism of action for its drug Bisantrene, which is believed to be a chemotherapy drug without side effects [4] - Trigg Minerals is exploring options for a NASDAQ listing, including a potential SPAC listing, as it targets the US critical metals market [5] - Fintech Stakk remains popular after securing deals with Robinhood and T-Mobile, alongside a $15 million placement currently under review [6]
HotCopper Highlights: Findi says its lawyers will deal with incident on the forums; Race hits all time high & more